ПОВОЛЖСКИЙ ОНКОЛОГИЧЕСКИЙ ВЕСТНИК 1 ( 28 )’ 2017
2 . Wilson M ., Rosato E . L ., Chojnacki K . A . et al . Prognostic significance of lymph node metastases and ratio in esophageal cancer // J . Surg . Res . — 2008 . — 146 . — P . 11-15 .
3 . Burmeister B . H ., Smithers B . M ., Gebski V ., et al . Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus : a randomised controlled phase III trial // Lancet Oncol . — 2005 . — 6 . — P . 659-68 .
4 . Tepper J ., Krasna M . J ., Niedzwiecki N ., et al . Phase III trial of trimodality therapy with cisplatin , fluorouracil , radiotherapy , and surgery compared with surgery alone for esophageal cancer : CALGB 9781 // J . Clin . Oncol . — 2008 . — 26 . — P . 1086-92 .
5 . Van Hagen P ., Hulshof M . C ., van Lanschot J . J ., et al . Preoperative chemoradiotherapy for esophageal or junctional cancer // N . Engl . J . Med . — 2012 . — 366 . — P . 2074-84 .
6 . Ancona E ., Ruol A ., Santi S ., et al . Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma : final report of a randomized , controlled trial of preoperative chemotherapy versus surgery alone // Cancer . — 2001 June 1 . — 91 ( 11 ). — P . 2165-74 .
7 . Kato H ., Fukuchi M ., Manda R , et al . The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas // Anticancer Res . — 2004 Nov-Dec . — 24 ( 6 ). — P . 4091-6 .
8 . Berger A . C ., Farma J ., Walter J . Scott , W . J . et al . Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival // Journal of Clinical Oncology . — July 2005 . — 23 , № 19 . — P . 4330-4337 .
9 . Donahue J . M ., Nichols F . C , Li Z . et al . Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival // Ann . Thorac . Surg . — 2009 Feb . — 87 ( 2 ). — P . 392-399 .
10 . Meredith K . L ., Weber J . M ., Turaga K . K . Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer // Ann . Surg . Oncol . — 2010 Apr . — 17 ( 4 ). — P . 1159-67 .
11 . Dittrick G . W ., Weber J . M ., Shridhar R ., et al . Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrated no survival benefit compared with patients treated with primary esophagectomy // Ann . Surg . Oncol . — 2012 . — 19 . — P . 1678-84 .
12 . Hsu P ., Chien L ., Huang C . et al . Comparison of survival among neoadjuvant chemoradiation responders , non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma : does neoadjuvant chemoradiation benefit all ? // Surgery . — 2013 Sep . — 17 ( 3 ). — P . 460-466 .
13 . McGlone E . R ., Khan O . A . Prognostic benefit of surgery following chemoradiotherapy for squamous cell carcinoma of the oesophagus // International Journal of Surgery . — Vol . 10 , Is . 7 . — P . 341-344 .
14 . Bedenne L ., Michel P ., Bouche O . et al . Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus : FFCD 9102 // Journal of clinical oncology . — April 2007 . — 25 , № 10 . — P . 1160-1168 .
15 . Stahl M ., Stuschke M ., Lehmann N ., et al . Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus // J . Clin . Oncol . — 23 . — 2310 . — P . 2005-2317 .
16 . Swisher S . G ., Maish M ., Erasmus J . J . et al . Utility of PET , CT , and EUS to identify pathologic responders in esophageal cancer // The annals of thoracicsurgery . — Осtоber 2004 . — Vol . 78 , Is . 4 . — P . 1152-1160 .
17 . Kim T . J ., Kim H . Y ., Lee K . W . Multimodality assessment of esophageal cancer : preoperative staging and monitoring of response to therapy // RadioGraphycs . — March-April 2009 . — Vol . 29 . — P . 403-421 .
18 . Westerterp M ., van Westreenen H . L ., Reitsma J . B . et al . Esophageal cancer : CT , endoscopic US , and FDG PET for assessment of response to neoadjuvant therapy — systematic review // Radiology . — 2005 . — 236 . — P . 841-851 .
19 . Therasse P ., Arbuck S . G ., Eisenhauer E . A . et al . New guidelines to evaluate the response to treatment in solid tumors . European Organization for Research and Treatment of Cancer , National Cancer Institute of the United States , National Cancer Institute of Canada // J . Natl . Cancer Inst . — 2000 . — 92 ( 3 ). — P . 205-216 .
20 . Лавникова Г . А . Некоторые закономерности лучевого патоморфоза опухолей человека и их практическое использование // Вестн . АМН СССР . — 1976 . — 6 . — С . 13-19 .
21 . Bollschweiler E ., Holscher A . H ., Schmidt M . and Warnecke-Eberz U . Neoadjuvant treatment for
М . В . Аглуллина и соавт . Эффективность рентгенологической и эндоскопической оценки ответа опухоли ... 9